Company Quick10K Filing
LifeVantage
10-Q 2020-03-31 Filed 2020-05-05
10-Q 2019-12-31 Filed 2020-01-28
10-Q 2019-09-30 Filed 2019-10-30
10-K 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-01
10-Q 2018-12-31 Filed 2019-02-04
10-Q 2018-09-30 Filed 2018-11-01
10-K 2018-06-30 Filed 2018-08-15
10-Q 2018-03-31 Filed 2018-05-09
10-Q 2017-12-31 Filed 2018-02-07
10-Q 2017-09-30 Filed 2017-11-08
10-K 2017-06-30 Filed 2017-09-07
10-Q 2017-03-31 Filed 2017-05-10
10-Q 2016-12-31 Filed 2017-02-08
10-Q 2016-09-30 Filed 2016-12-12
10-K 2016-06-30 Filed 2016-12-12
10-Q 2016-03-31 Filed 2016-05-04
10-Q 2015-12-31 Filed 2016-02-09
10-Q 2015-09-30 Filed 2015-11-04
10-K 2015-06-30 Filed 2015-09-01
10-Q 2015-03-31 Filed 2015-05-06
10-Q 2014-12-31 Filed 2015-02-04
10-Q 2014-09-30 Filed 2014-11-06
10-K 2014-06-30 Filed 2014-09-10
10-Q 2014-03-31 Filed 2014-05-06
10-Q 2013-12-31 Filed 2014-02-06
10-Q 2013-09-30 Filed 2013-11-07
10-K 2013-06-30 Filed 2013-09-12
10-Q 2013-03-31 Filed 2013-05-09
10-Q 2012-12-31 Filed 2013-02-07
10-Q 2012-09-30 Filed 2012-11-08
10-K 2012-06-30 Filed 2012-09-10
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-K 2011-06-30 Filed 2011-09-28
10-Q 2011-03-31 Filed 2011-05-16
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-08
10-K 2010-06-30 Filed 2010-09-15
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-05-05
8-K 2020-01-28
8-K 2020-01-09
8-K 2019-12-05
8-K 2019-10-30
8-K 2019-08-14
8-K 2019-08-09
8-K 2019-05-08
8-K 2019-05-01
8-K 2019-02-04
8-K 2019-01-10
8-K 2018-11-15
8-K 2018-11-01
8-K 2018-08-15
8-K 2018-07-26
8-K 2018-05-09
8-K 2018-03-09
8-K 2018-02-07
8-K 2018-02-07
8-K 2018-01-08

LifeVantage Financials

LFVN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Geron (GERN) 255,317 0% -5.0 -28% 164,254 11,862 664 0 -46,778 -46,778 234,296
Celyad (CYAD) 237,891 0% 94,299 0 0 0 0 197,349
Xenon Pharmaceuticals (XENE) 231,524 0% -7.3 -31% 98,904 24,340 3,500 0 -30,219 -28,837 209,353
Evelo Biosciences (EVLO) 228,674 -1.9 -70% 111,140 30,594 0 0 -78,316 -78,316 149,662
Kalvista Pharmaceuticals (KALV) 221,322 0% -7.9 -23% 112,064 14,277 14,105 0 -25,723 -25,353 199,603
LifeVantage (LFVN) 220,548 83% 16.8 15% 56,000 26,376 226,577 188,613 8,279 12,329 207,539
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Minerva Neurosciences (NERV) 213,079 -3.2 -50% 110,813 55,286 0 0 -55,469 -55,456 175,073
Galectin Therapeutics (GALT) 211,338 -19.9 -16% 50,760 1,278 0 0 -8,157 -8,092 161,001
Spero Therapeutics (SPRO) 210,332 0% -3.6 -41% 112,510 19,476 16,209 0 -46,538 -45,677 164,735
Chiasma (CHMA) 208,767 -5.9 -30% 106,883 10,143 0 0 -32,348 -32,314 189,102
Palatin Technologies (PTN) 207,471 0% -7.4 -16% 97,973 1,850 158 0 -15,218 -14,949 110,773
Athersys (ATHX) 206,505 0% -3.5 -100% 47,431 20,429 6,859 0 -47,615 -47,615 166,059
Cue Biopharma (CUE) 205,122 0% -6.3 -61% 45,209 18,187 2,409 0 -27,779 -27,366 173,593
Osmotica Pharmaceuticals (OSMT) 201,617 50% -1.2 -70% 494,173 352,476 180,120 90,960 -345,919 -307,828 371,662
Enochian Biosciences (ENOB) 196,664 -8.6 -11% 180,620 8,438 0 0 -19,796 -21,662 185,526
Kamada (KMDA) 193,416 0% 138,116 0 0 0 0 175,398
Mallinckrodt (MNK) 189,450 44% -1.8 -34% 10,356,100 7,275,700 3,192,500 1,411,600 -3,557,800 -2,608,600 4,755,850
Glycomimetics (GLYC) 184,713 -0.2 -32% 180,455 13,374 0 0 -57,073 -57,073 13,827
Aratana Therapeutics (PETX) 183,720 71% -13.7 -12% 104,712 8,494 38,729 27,360 -12,961 -10,702 146,808

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash9,43713,46116,89624,64825,17828,46627,23926,29927,95734,45435,68120,38722,13518,64715,35313,90513,68615,8198,4947,88310,22511,7319,20211,45812,28812,79413,95216,65217,12318,98915,91318,82413,009
Accounts Receivable1,3167598173332307281,3811,7899238732,6061,3171,6571,1061,2581,0311,1441,7382,0421,5521,4347171,1511,3341,6611,5421,3292,0672,3672,3761,9162,0662,123
Inventory2,7563,0346,98111,35313,0669,5528,02510,52410,6259,8438,5768,82611,00912,09910,8999,2488,53810,61917,00225,11623,91721,37719,14516,57515,36016,81915,81613,62713,28113,30114,49013,75314,776
PP&E5531,1501,7671,9973,3605,6715,9265,6925,4905,2797,1836,9416,5406,5336,2395,7595,2675,1804,9813,4563,1632,8852,8783,1273,9904,6445,6606,5876,0635,8486,8187,1317,380
Assets17,10524,66733,37644,52850,02154,82854,47955,48454,46363,39470,30253,99956,68451,05446,92640,87939,60244,92744,12050,25949,79646,51546,74345,24944,79345,65650,92951,14251,92154,09354,10555,27356,000
Accounts Payable1,2101,67903,6162,4244,7784,6085,1713,0002,8052,6412,8544,2174,0022,7232,6142,5025,8575,9388,8917,7305,0376,4934,8503,1543,2694,6293,8133,9304,1085,0655,1805,148
Long-Term Debt42,30041,12526,12524,95023,77518,10010,4846,7862,5838,0007,5007,0006,5006,0005,5005,0004,5004,0003,5003,0002,50000
Liabilities33,30915,33510,84516,24515,90219,79519,62221,53919,38063,94267,57550,00949,48846,50744,09637,55435,02537,91835,28138,12835,71432,00432,84830,72229,02129,15131,62729,19528,39033,07529,35928,07426,376
Stockholders' Equity-16,2049,33322,53128,28334,11935,03334,85733,94535,083-5482,7273,9907,1964,5472,8303,3254,5777,0098,83912,13114,08214,51113,89514,52715,77216,50519,30221,94723,53121,01824,74627,19929,624
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue20,08325,28436,21244,60452,85970,08550,37051,51151,32852,49655,06456,03851,63348,24745,15545,30145,35251,99556,16053,03354,89448,94745,00750,64149,12749,48250,56254,03355,60958,16756,01256,17056,228
Cost of Revenue2,9573,6804,9896,4277,80711,6177,3307,9097,8098,4238,4598,9825,6797,4867,5527,2936,9757,8429,7149,4018,8327,5008,2338,8918,7399,1178,9218,0709,1999,7949,2709,7109,190
Gross Profit17,12721,60431,22338,17745,05252,58943,50144,22243,51943,61246,60547,05645,95440,76137,60338,00838,37744,15346,44643,63246,06241,44736,77441,75040,38840,36541,64145,96246,41048,37346,74246,46047,038
R&D235312378435514879848843307584655454500545600600200300200300300300200300300300300400400500100100200
SG&A13,38216,91424,29230,20537,39346,95238,21442,65737,64337,74440,95313,61514,47614,48114,78113,66313,82414,63013,95717,78017,20713,70816,22715,58114,64315,02314,59417,30119,61617,29615,33817,686
Tax4721,7035871,4212,7012,970970-641,8522,7256951,2062,4445871514841,2078197744322,162129-11,0414411,7381,3221,072755-4203761,591689
Net Income3,7248,759-4,8464,8324,1652093,417-1823,2563,2822,4942,3514,7161,4725732261,0661,6001,0032,3501,18028361848173171,6352,9929118291,7823,9071,761
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3,3404,7043,6227,7239155,4483,7045954,8532,0633,2611,9285,0622,9049954,2602,8415,665-2,308-2122,8802,220-4791,9762,5032,1793,1035,4712,3663,8636,984-3,460
Cash Investing-369-330-744-453-1,567-2,303-755-455-295-364-1,012-577-236-627-240-56-3-330-166-63-94-143-227-591-1,176-941-1,250-1,282-1,486-1,417-817-752
Cash Financing12-3596384551,18776-4,090-1,196-2,6124,908-1,088-17,012-3,140-5,624-4,035-5,655-3,135-3,189-4,931-442-495-498-1,847882-500-750-720-1,529-328-5,492-3,313-1,604